CIOMP OpenIR  > 中科院长春光机所知识产出
Bcl-2 inhibitor uploaded upconversion nanophotosensitizers to overcome the photodynamic therapy resistance of cancer through adjuvant intervention strategy
Liu, X. M.; Z. Q. Fan; L. Zhang; Z. Jin; D. M. Yan; Y. L. Zhang; X. D. Li; L. P. Tu; B. Xue; Y. L. Chang; H. Zhang and X. G. Kong
2017
发表期刊Biomaterials
卷号144
摘要Similar to many other anticancer therapies, photodynamic therapy (PDT) also suffers from the intrinsic cancer resistance mediated by cell survival pathways. These survival pathways are regulated by various proteins, among which anti-apoptotic protein Bcl-2 plays an important role in regulation of programmed cell death and has been proved to involve in protecting against oxidative stimuli. Confronted by this challenge, we propose and validate here a novel upconversion photosensitizing nanoplatform which enables significant reduction of cancer resistance and improve PDT efficacy. The upconversion nano-photosensitizer contains the photosensitizing molecules - Zinc phthalocyanine (ZnPc) and Bcl-2 inhibitor - ABT737 small molecules, denoted as ABT737@ZnPc-UCNPs. ABT737 molecules were encapsulated, in a pH sensitive way, into the nanoplatform through Poly (ethylene glycol)-Poly (L-histidine) diblock copolymers (PEG-b-PHis). This nanosystem exhibits the superiority of sensitizing tumor cells for PDT through adjuvant intervention strategy. Upon reaching to lysosomes, the acidic environment changes the solubility of PEG-b-PHis, resulting in the burst-release of ABT737 molecules which deplete the Bcl-2 level in tumor cells and leave the tumor cells out from the protection of anti-apoptotic survival pathway in advance. Owing to the sensitization effect of ABT737@ZnPc-UCNPs, the PDT therapeutic efficiency of cancer cells can be significantly potentiated in vitro and in vivo. (C) 2017 Published by Elsevier Ltd.
收录类别sci ; ei
语种英语
文献类型期刊论文
条目标识符http://ir.ciomp.ac.cn/handle/181722/59098
专题中科院长春光机所知识产出
推荐引用方式
GB/T 7714
Liu, X. M.,Z. Q. Fan,L. Zhang,et al. Bcl-2 inhibitor uploaded upconversion nanophotosensitizers to overcome the photodynamic therapy resistance of cancer through adjuvant intervention strategy[J]. Biomaterials,2017,144.
APA Liu, X. M..,Z. Q. Fan.,L. Zhang.,Z. Jin.,D. M. Yan.,...&H. Zhang and X. G. Kong.(2017).Bcl-2 inhibitor uploaded upconversion nanophotosensitizers to overcome the photodynamic therapy resistance of cancer through adjuvant intervention strategy.Biomaterials,144.
MLA Liu, X. M.,et al."Bcl-2 inhibitor uploaded upconversion nanophotosensitizers to overcome the photodynamic therapy resistance of cancer through adjuvant intervention strategy".Biomaterials 144(2017).
条目包含的文件 下载所有文件
文件名称/大小 文献类型 版本类型 开放类型 使用许可
Bcl-2 inhibitor uplo(4823KB)期刊论文作者接受稿开放获取CC BY-NC-SA浏览 下载
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Liu, X. M.]的文章
[Z. Q. Fan]的文章
[L. Zhang]的文章
百度学术
百度学术中相似的文章
[Liu, X. M.]的文章
[Z. Q. Fan]的文章
[L. Zhang]的文章
必应学术
必应学术中相似的文章
[Liu, X. M.]的文章
[Z. Q. Fan]的文章
[L. Zhang]的文章
相关权益政策
暂无数据
收藏/分享
文件名: Bcl-2 inhibitor uploaded upconversion nanophotosensitizers to overcome the photodynamic therapy resistance of cancer through adjuvant intervention strategy.pdf
格式: Adobe PDF
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。